Sanofi (Mexico) Performance
| SNYN Stock | MXN 834.00 17.66 2.16% |
Sanofi has a performance score of 7 on a scale of 0 to 100. The entity has a beta of 0.28, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Sanofi's returns are expected to increase less than the market. However, during the bear market, the loss of holding Sanofi is expected to be smaller as well. Sanofi right now has a risk of 1.19%. Please validate Sanofi total risk alpha, treynor ratio, value at risk, as well as the relationship between the sortino ratio and maximum drawdown , to decide if Sanofi will be following its existing price patterns.
Risk-Adjusted Performance
7 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Sanofi are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Sanofi may actually be approaching a critical reversion point that can send shares even higher in June 2024. ...more
| Begin Period Cash Flow | 10.1 B |
Sanofi |
Sanofi Relative Risk vs. Return Landscape
If you would invest 78,003 in Sanofi on February 17, 2024 and sell it today you would earn a total of 5,397 from holding Sanofi or generate 6.92% return on investment over 90 days. Sanofi is generating 0.1203% of daily returns and assumes 1.1887% volatility on return distribution over the 90 days horizon. Simply put, 10% of stocks are less volatile than Sanofi, and 98% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Sanofi Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sanofi's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Sanofi, and traders can use it to determine the average amount a Sanofi's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1012
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | SNYN | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.19 actual daily | 10 90% of assets are more volatile |
Expected Return
| 0.12 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average Sanofi is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sanofi by adding it to a well-diversified portfolio.
Sanofi Fundamentals Growth
Sanofi Stock prices reflect investors' perceptions of the future prospects and financial health of Sanofi, and Sanofi fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sanofi Stock performance.
| Return On Equity | 0.0959 | |||
| Return On Asset | 0.0607 | |||
| Profit Margin | 0.15 % | |||
| Operating Margin | 0.26 % | |||
| Current Valuation | 2.69 T | |||
| Shares Outstanding | 2.47 B | |||
| Price To Earning | 414.95 X | |||
| Price To Book | 1.61 X | |||
| Price To Sales | 52.71 X | |||
| Revenue | 45.39 B | |||
| EBITDA | 10.76 B | |||
| Cash And Equivalents | 8.73 B | |||
| Cash Per Share | 3.50 X | |||
| Total Debt | 14.86 B | |||
| Debt To Equity | 47.20 % | |||
| Book Value Per Share | 29.16 X | |||
| Cash Flow From Operations | 10.52 B | |||
| Earnings Per Share | 56.31 X | |||
| Total Asset | 124.58 B | |||
About Sanofi Performance
To evaluate Sanofi Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Sanofi generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Sanofi Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Sanofi market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Sanofi's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.It offers Cerezyme and Cerdelga for Gaucher, Myozyme and Lumizyme for Pompe, Fabrazyme for Fabry, and Aldurazyme for mucopolysaccharidosis Type 1 and Aubagio, an immunomodulatory and Lemtrada, a monoclonal antibody for multiple sclerosis. Sanofi was founded in 1973 and is headquartered in Paris, France. SANOFI is traded on Mexico Stock Exchange in Mexico.Things to note about Sanofi performance evaluation
Checking the ongoing alerts about Sanofi for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Sanofi help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Evaluating Sanofi's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Sanofi's stock performance include:- Analyzing Sanofi's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sanofi's stock is overvalued or undervalued compared to its peers.
- Examining Sanofi's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Sanofi's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sanofi's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Sanofi's stock. These opinions can provide insight into Sanofi's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sanofi. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Complementary Tools for Sanofi Stock analysis
When running Sanofi's price analysis, check to measure Sanofi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi is operating at the current time. Most of Sanofi's value examination focuses on studying past and present price action to predict the probability of Sanofi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi's price. Additionally, you may evaluate how the addition of Sanofi to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |